STERIS’ (TSE:STE – Free Report) – Equities research analysts at Cormark lowered their FY2025 earnings estimates for STERIS’ in a report issued on Monday, January 6th. Cormark analyst B. Watson now expects that the company will post earnings per share of $0.38 for the year, down from their previous estimate of $0.86. Cormark currently has a “Moderate Buy” rating on the stock.
Separately, Atb Cap Markets upgraded STERIS’ to a “strong-buy” rating in a report on Sunday, December 22nd.
STERIS’ Price Performance
About STERIS’
STERIS’s MISSION IS TO HELP OUR CUSTOMERS CREATE A HEALTHIER AND SAFER WORLD by providing innovative healthcare and life science product and service solutions around the globe by providing innovative healthcare and life science product and service solutions around the globe.
Featured Stories
- Five stocks we like better than STERIS’
- 3 Dividend Kings To Consider
- Driving Forward: Lucid’s Growing Sales and Gravity SUV’s Impact
- Are Penny Stocks a Good Fit for Your Portfolio?
- Why Amazon’s Next Earnings Could Trigger a Stock Breakout
- Using the MarketBeat Stock Split Calculator
- With This Kind of Data, The Fed Isn’t Cutting Rates This Year
Receive News & Ratings for STERIS’ Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for STERIS’ and related companies with MarketBeat.com's FREE daily email newsletter.
